AP9901698A0 - Novel process. - Google Patents
Novel process.Info
- Publication number
- AP9901698A0 AP9901698A0 APAP/P/1999/001698A AP9901698A AP9901698A0 AP 9901698 A0 AP9901698 A0 AP 9901698A0 AP 9901698 A AP9901698 A AP 9901698A AP 9901698 A0 AP9901698 A0 AP 9901698A0
- Authority
- AP
- ARIPO
- Prior art keywords
- compounds
- novel process
- paroxetine
- structures
- reduction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compounds of structure (1)are obtained by reduction of compounds of the structures (2a), (2b), (4a), (4b). Compounds of structure (1), especially where z is a hydrogen atom or a 3,4-methylenedioxyphenyl group, are important intermediates for inter alia paroxetine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9711095.1A GB9711095D0 (en) | 1997-05-29 | 1997-05-29 | Novel process |
GBGB9714875.3A GB9714875D0 (en) | 1997-07-15 | 1997-07-15 | Novel process |
PCT/US1998/011057 WO1998053824A1 (en) | 1997-05-29 | 1998-05-29 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
AP9901698A0 true AP9901698A0 (en) | 1999-12-31 |
Family
ID=26311618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1999/001698A AP9901698A0 (en) | 1997-05-29 | 1998-05-29 | Novel process. |
Country Status (22)
Country | Link |
---|---|
US (3) | US6489347B1 (en) |
EP (1) | EP0986389B1 (en) |
JP (1) | JP2002514222A (en) |
CN (1) | CN1268889A (en) |
AP (1) | AP9901698A0 (en) |
AT (1) | ATE279393T1 (en) |
AU (1) | AU7708998A (en) |
BG (1) | BG104034A (en) |
BR (1) | BR9809687A (en) |
CA (1) | CA2291251A1 (en) |
DE (1) | DE69827000D1 (en) |
EA (1) | EA199901098A1 (en) |
HU (1) | HUP0003958A3 (en) |
ID (1) | ID24383A (en) |
IL (1) | IL133140A0 (en) |
NO (1) | NO995796D0 (en) |
NZ (1) | NZ501285A (en) |
OA (1) | OA11223A (en) |
PL (1) | PL337513A1 (en) |
SK (1) | SK159899A3 (en) |
TR (1) | TR199902929T2 (en) |
WO (1) | WO1998053824A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6438585B2 (en) * | 1998-05-29 | 2002-08-20 | Research In Motion Limited | System and method for redirecting message attachments between a host system and a mobile data communication device |
WO2000026187A1 (en) * | 1998-11-02 | 2000-05-11 | Synthon B.V. | Process for producing 4-arylpiperidine-3-carbinols and related compounds |
US20010053862A1 (en) * | 1998-12-22 | 2001-12-20 | Bruce Ronsen | Process for preparing arylpiperidine carbinol intermediates and derivatives |
GB9828767D0 (en) * | 1998-12-29 | 1999-02-17 | Smithkline Beecham Plc | Novel process |
IT1313702B1 (en) * | 1999-08-02 | 2002-09-09 | Chemi Spa | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED DERIVATIVES OF 4-PHENYL-PIPERIDINS. |
GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
US6833458B2 (en) * | 2000-06-05 | 2004-12-21 | Development Center For Biotechnology | Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates |
WO2002053537A1 (en) | 2001-01-04 | 2002-07-11 | Ferrer Internacional, S.A. | Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
DE20220955U1 (en) | 2001-10-22 | 2004-09-02 | Synthon B.V. | Composition useful for treating e.g. depression, anxiety, obsessive-compulsive disorder, obesity comprises N-formyl paroxetine and a paroxetine compound |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
CN112645951A (en) * | 2020-12-23 | 2021-04-13 | 上海博栋化学科技有限公司 | Sulfonium sulfonate photo-acid generator synthesized from vinblastine and synthetic method thereof |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798432A (en) * | 1945-02-27 | 1957-07-09 | Leo T Meister | Delay action fuse |
US2498432A (en) | 1946-07-08 | 1950-02-21 | Hoffmann La Roche | 1-branched lower alkyl-4-phenyl-4-acyloxy-piperidines and their acid addition salts |
GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
US4585777A (en) | 1984-02-07 | 1986-04-29 | A/S Ferrosan | (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT |
US4593036A (en) | 1984-02-07 | 1986-06-03 | A/S Ferrosan | (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator |
EP0190496A3 (en) | 1984-12-13 | 1987-05-27 | Beecham Group Plc | Piperidine derivatives having a gastro-intestinal activity |
GB8520154D0 (en) | 1985-08-10 | 1985-09-18 | Beecham Group Plc | Chemical process |
EP0223334B1 (en) | 1985-08-10 | 1991-07-10 | Beecham Group Plc | Process for the preparation of aryl-piperidine carbinols |
GB8714707D0 (en) | 1987-06-23 | 1987-07-29 | Beecham Group Plc | Chemical process |
DK715988D0 (en) | 1988-12-22 | 1988-12-22 | Ferrosan As | ETHERIFICATION AND DEALKYLING OF PIPERIDINE DERIVATIVES AND INTERMEDIATES |
IL98757A (en) | 1990-07-18 | 1997-01-10 | Novo Nordisk As | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
US5258517A (en) * | 1992-08-06 | 1993-11-02 | Sepracor, Inc. | Method of preparing optically pure precursors of paroxetine |
GB9305175D0 (en) | 1993-03-13 | 1993-04-28 | Smithkline Beecham Plc | Novel process |
ES2102295B1 (en) | 1994-03-18 | 1998-04-01 | Ferrer Int | NEW COMPOUNDS DERIVED FROM N-BENZOILMETIL-PIPERIDINA. |
US5856493A (en) | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
US5554383A (en) * | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
JPH11505229A (en) | 1995-05-17 | 1999-05-18 | ノボ ノルディスク アクティーゼルスカブ | Method for producing 4-aryl-piperidine derivatives |
IL123293A (en) | 1995-09-07 | 2003-06-24 | Hoffmann La Roche | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
ES2121685B1 (en) * | 1996-04-10 | 1999-09-16 | Vita Invest Sa | PROCEDURE FOR THE OBTAINING OF (+) - TRANS-4 (4-FLUORO-FENIL) -3-HIDROXIMETIL-1-METHYLPIPERIDINE. |
JP3446468B2 (en) * | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | Method for producing piperidine carbinols |
EP1384711A1 (en) | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Optical resolution of a piperidine derivative |
DE69840909D1 (en) | 1997-04-07 | 2009-07-30 | Univ Georgetown | ANALOG OF COCAINE |
WO2000026187A1 (en) | 1998-11-02 | 2000-05-11 | Synthon B.V. | Process for producing 4-arylpiperidine-3-carbinols and related compounds |
US6051812A (en) * | 1998-11-16 | 2000-04-18 | Walker; Lawrence | Snow and ice melting blanket device |
-
1998
- 1998-05-29 HU HU0003958A patent/HUP0003958A3/en unknown
- 1998-05-29 ID IDW991488A patent/ID24383A/en unknown
- 1998-05-29 EA EA199901098A patent/EA199901098A1/en unknown
- 1998-05-29 SK SK1598-99A patent/SK159899A3/en unknown
- 1998-05-29 CN CN98805522A patent/CN1268889A/en active Pending
- 1998-05-29 AT AT98925055T patent/ATE279393T1/en not_active IP Right Cessation
- 1998-05-29 AU AU77089/98A patent/AU7708998A/en not_active Abandoned
- 1998-05-29 TR TR1999/02929T patent/TR199902929T2/en unknown
- 1998-05-29 BR BR9809687-7A patent/BR9809687A/en not_active Application Discontinuation
- 1998-05-29 AP APAP/P/1999/001698A patent/AP9901698A0/en unknown
- 1998-05-29 EP EP98925055A patent/EP0986389B1/en not_active Expired - Lifetime
- 1998-05-29 US US09/087,632 patent/US6489347B1/en not_active Expired - Fee Related
- 1998-05-29 CA CA002291251A patent/CA2291251A1/en not_active Abandoned
- 1998-05-29 JP JP50100199A patent/JP2002514222A/en not_active Ceased
- 1998-05-29 IL IL13314098A patent/IL133140A0/en unknown
- 1998-05-29 DE DE1998627000 patent/DE69827000D1/en not_active Expired - Lifetime
- 1998-05-29 PL PL98337513A patent/PL337513A1/en unknown
- 1998-05-29 WO PCT/US1998/011057 patent/WO1998053824A1/en not_active Application Discontinuation
- 1998-05-29 NZ NZ501285A patent/NZ501285A/en unknown
-
1999
- 1999-11-26 NO NO995796A patent/NO995796D0/en not_active Application Discontinuation
- 1999-11-29 OA OA9900263A patent/OA11223A/en unknown
- 1999-12-17 BG BG104034A patent/BG104034A/en unknown
-
2002
- 2002-05-03 US US10/138,553 patent/US6716985B2/en not_active Expired - Fee Related
-
2004
- 2004-01-14 US US10/757,147 patent/US20040147754A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040147754A1 (en) | 2004-07-29 |
US6489347B1 (en) | 2002-12-03 |
IL133140A0 (en) | 2001-03-19 |
EP0986389B1 (en) | 2004-10-13 |
PL337513A1 (en) | 2000-08-28 |
SK159899A3 (en) | 2000-06-12 |
NO995796L (en) | 1999-11-26 |
EP0986389A1 (en) | 2000-03-22 |
EA199901098A1 (en) | 2000-08-28 |
BR9809687A (en) | 2000-07-11 |
OA11223A (en) | 2003-06-17 |
CN1268889A (en) | 2000-10-04 |
US20020133011A1 (en) | 2002-09-19 |
JP2002514222A (en) | 2002-05-14 |
EP0986389A4 (en) | 2001-09-12 |
US6716985B2 (en) | 2004-04-06 |
NZ501285A (en) | 2001-10-26 |
BG104034A (en) | 2000-11-30 |
NO995796D0 (en) | 1999-11-26 |
ATE279393T1 (en) | 2004-10-15 |
DE69827000D1 (en) | 2004-11-18 |
WO1998053824A1 (en) | 1998-12-03 |
HUP0003958A2 (en) | 2001-05-28 |
HUP0003958A3 (en) | 2001-06-28 |
AU7708998A (en) | 1998-12-30 |
ID24383A (en) | 2000-07-13 |
CA2291251A1 (en) | 1998-12-03 |
TR199902929T2 (en) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601857D0 (en) | New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them | |
HUT56558A (en) | Process for producing oxetanones | |
MY138525A (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
TR200800474T2 (en) | Process for the preparation of intermediates of fluorfenicol. | |
ES2133769T3 (en) | PROCEDURE FOR DIASTEREOSELECTIVE SYNTHESIS OF NUCLEOSID ANALOGS. | |
IL134468A0 (en) | 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same | |
HU9700884D0 (en) | New intermediates and process for producing them | |
AP9901698A0 (en) | Novel process. | |
HU9700886D0 (en) | New intermediates and process for producing them | |
MY116862A (en) | New processes for preparing pesticidal intermediates | |
YU12000A (en) | Substituted 1,2,3,4,,5,6,-hexahydro-2,6-methano-3- benzazocine-10-oles, method for the production and use thereof as medicaments | |
NO981393L (en) | Guanidinoproteasehemmere | |
EA199900790A1 (en) | METHODS OF OBTAINING PESTICIDAL INTERMEDIATE COMPOUNDS | |
ES2185459A1 (en) | A process for the preparation of pantoprazole and intermediates therefor | |
HU9400020D0 (en) | New process for producing sulphur-derivatives of imidazole, and the obtained new intermediates | |
MXPA03002493A (en) | Efficient process for the preparation of a factor xa inhibitor. | |
GB9909229D0 (en) | Enantiomers of mercapto lactones and processes for their synthesis | |
AU7214298A (en) | Process for making a butylthio-isoquinoline and intermediates therefor | |
IL139773A0 (en) | Morphine-6-glucuronide synthesis | |
YU71400A (en) | Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives | |
MX9603450A (en) | Process for the obtention of substituted aminotriazolines. | |
MX9702486A (en) | The manufacture of levobupivacaine and analogues thereof from l-lysine. | |
IT1251877B (en) | PROCESS FOR THE PREPARATION OF 2-AMINO-5,6 DIMETOXY-TETRALINE | |
ATE244217T1 (en) | PRODUCTION OF BETA-MEHTYLCARBAPENEM INTERMEDIATE PRODUCTS | |
MX9601818A (en) | Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines. |